Liposome AIDS vaccine delivery
Executive Summary
Venture between Biotechnology Development Corp. and Immune Response Corp. will develop formulations for administration of an experimental vaccine developed in the lab of Dr. Jonas Salk. Liposome formulations will be developed by BDC subsidiary, Medicontrol, in return for a fee from IRC as well as royalty on sales of product and licensing income. Medicontrol currently has a liposome formulation agreement with Searle ("The Pink Sheet" Sept. 29, 1986, T&G-3).